在高容量学术机构治疗原发性非转移性黑色素瘤与患者长期生存改善相关
基于美国国家癌症数据库2004至2014年成人原发性非转移性黑色素瘤病例,按医院年病例量四分位分组分析。病例量越高患者长期生存越好,5年生存率在低、中、高四分位组分别为76.8%、81.9%、86.4%;学术附属仅在高四分位容量机构与结局改善相关。
要点
- 医院年病例量越高,原发性非转移性黑色素瘤患者长期生存越好(P < .0001)。
- 5年生存率低、中、高容量四分位组分别为76.8%、81.9%、86.4%。
- 学术附属仅在高容量四分位机构与结局改善相关,中容量组无关。
核心结论
- 在高容量机构治疗与黑色素瘤患者长期生存改善相关。
- 高容量学术中心相比其他高容量中心患者结局更好。
研究设计与样本
- 识别2004至2014年美国成人中诊断并纳入国家癌症数据库的黑色素瘤病例。
- 医院按年病例量四分位分组:最低四分位、中间两个四分位、最高四分位。
主要发现
- 机构病例量与患者长期生存显著相关(P < .0001)。
- 5年生存率在最低、中间、最高病例量四分位机构治疗的患者分别为76.8%、81.9%、86.4%。
- 多因素分析中,中间两个四分位容量中心治疗(风险比0.834;95%置信区间0.778-0.895)和最高四分位容量中心治疗(风险比0.691;95%置信区间0.644-0.741)相对最低四分位容量医院治疗与生存改善相关。
- 学术附属与最高四分位容量机构结局改善相关,与中间四分位容量机构无关。
局限性
- 疾病特异性生存数据不可获得。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Previous studies of cancer care have demonstrated improved long-term patient outcomes for those treated at high-volume centers. The influence of treatment center characteristics on outcomes for primary nonmetastatic melanoma is not currently established. OBJECTIVE: We aimed to investigate the association of cancer treatment center case volume and academic affiliation with long-term patient survival for cases of primary nonmetastatic melanoma. METHODS: Cases of melanoma diagnosed in US adults from 2004 to 2014 and included in the National Cancer Database were identified. Hospitals were grouped by yearly case-volume quartile: bottom quartile, 2 middle quartiles, and top quartile. RESULTS: Facility case volume was significantly associated with long-term patient survival (P < .0001). The 5-year survival rates were 76.8%, 81.9%, and 86.4% for patients treated at institutions in the bottom, middle, and top quartiles of case volume, respectively. On multivariate analysis, treatment at centers in both middle quartiles (hazard ratio, 0.834; 95% confidence interval, 0.778-0.895) and in the top quartile (hazard ratio, 0.691; 95% confidence interval, 0.644-0.741) of case volume was associated with improved survival relative to that of patients treated at hospitals in the bottom quartile of case volume. Academic affiliation was associated with improved outcomes for top-quartile- but not middle-quartile-volume facilities. LIMITATIONS: Disease-specific survival was not available. CONCLUSIONS: Treatment at a high-volume facility is associated with improved long-term patient survival for melanoma. High-volume academic centers have improved patient outcomes compared with other high-volume centers.
引用
- Cheraghlou S, Agogo GO, Girardi M, et al. Treatment of primary nonmetastatic melanoma at high-volume academic facilities is associated with improved long-term patient survival. J Am Acad Dermatol. 2018. PMID: 30365997. doi:10.1016/j.jaad.2018.10.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。